Cite
[Adjuvant chemo radiotherapy after gastrectomy and D2 lymphadenectomy in patients with gastric cancer in the National Institute of Cancer, Lima, Peru].
MLA
Montenegro, Paola, et al. “[Adjuvant Chemo Radiotherapy after Gastrectomy and D2 Lymphadenectomy in Patients with Gastric Cancer in the National Institute of Cancer, Lima, Peru].” Revista de Gastroenterologia Del Peru : Organo Oficial de La Sociedad de Gastroenterologia Del Peru, vol. 33, no. 1, Jan. 2013, pp. 34–38. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=23539054&authtype=sso&custid=ns315887.
APA
Montenegro, P., Flores, L., Quintana, S., Casanova, L., Ruíz, E., León, J., & Mantilla, R. (2013). [Adjuvant chemo radiotherapy after gastrectomy and D2 lymphadenectomy in patients with gastric cancer in the National Institute of Cancer, Lima, Peru]. Revista de Gastroenterologia Del Peru : Organo Oficial de La Sociedad de Gastroenterologia Del Peru, 33(1), 34–38.
Chicago
Montenegro, Paola, Lourdes Flores, Shirley Quintana, Luís Casanova, Eloy Ruíz, Jorge León, and Raúl Mantilla. 2013. “[Adjuvant Chemo Radiotherapy after Gastrectomy and D2 Lymphadenectomy in Patients with Gastric Cancer in the National Institute of Cancer, Lima, Peru].” Revista de Gastroenterologia Del Peru : Organo Oficial de La Sociedad de Gastroenterologia Del Peru 33 (1): 34–38. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=23539054&authtype=sso&custid=ns315887.